This information was published on 2026-07-03T13:34:36 for IP Right Filed Published.
| Field | Value |
| (210) | 2673820 |
| (220) |
03 Jul 2026
|
| (511) (510) |
Class 5
Glycerin based ingredient sold as integral component of ophthalmic preparations; glycerin based ingredient sold as integral component of eye drops; glycerin based ingredient sold as integral component of lubricating and rewetting solutions for eyes |
| (540) |
|
| (550) | Figurative |
| (730) |
Allergan, Inc.
|
| (750) |
Ashurst Perkins Coie Australia
|
Find out more about publications on the About page.